Vorinostat and bone metabolism disorder Patient Reports February 12, 2012

Vorinostat Side Effects Report #5809587-5
Vorinostat side effect was reported by a Physician from GERMANY on June 12, 2008. Female patient, 48 years of age, was diagnosed with mycosis fungoides and was treated with Vorinostat. After drug was administered, patient experienced the following side effects: bone metabolism disorder, condition aggravated, hypercalcaemia, mycosis fungoides, renal failure, thrombocytopenia. Vorinostat dosage: 400 MG/DAILY PO. Patient was hospitalized and became disabled. Patient recovered.